Overexpression of the proteasome subunits LMP2, LMP2, and MECL-1, but not PA28α/β, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 768-778

  Schwarz, Katrin ^a   Van Den Broek, Maries ^b   Kostka, Susanne ^c   Kraft, Regine ^c   Soza, Andrea ^d,e   Schmidtke, Gunter ^a   Kloetzel, Peter M ^d   Groettrup, Marcus ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; ENZYME SUBUNIT; EPITOPE MAPPING; GENE OVEREXPRESSION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS MENINGITIS;

EID: 0034662001     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.768     Document Type: Article

References (64)

1. Rammensee, H. G., K. Falk, and O. Rötzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:213.
2. Uebel, S., and R. Tampe. 1999. Specificity of the proteasome and the TAP transporter. Curr. Opin. Immunol. 11:203.
3. Neefjes, J., E. Gottfried, J. Roelse, M. Gromme, R. Obst, G. J. Hämmerling, and F. Momburg. 1995. Analysis of the fine specificity of rat, mouse and human TAP peptide transporters. Eur. J. Immunol. 25:1133.
4. Paz, P., N. Brouwenstijn, R. Perry, and N. Shastri. 1999. Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER. Immunity 11:241.
5. Groettrup, M., A. Soza, U. Kuckelkorm, and P. M. Kloetzel. 1996. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today 17:429.
6. Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20 S and 26 S proteasomes. Annu. Rev. Biochem. 65:801.
7. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761.
8. Cerundolo, V., A. Benham, V. Braud, S. Mukherjee, K. Gould, B. Macino, J. Neefjes, and A. Townsend. 1997. The proteasome-specitic inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 27:336.
9. Craiu, A., M. Gaczynska, T. Akopian, C. F. Gramm, G. Fenteany, A. L. Goldberg, and K. L. Rock. 1997. Lactacyslin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class 1 antigen presentation. J. Biol. Chem. 272:13437.
10. Gallimore, A., K. Schwarz, M. van den Broek, H. Hengartner, and M. Groettrup. 1998. The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope. Mol. Immunol. 35:581.
11. Gaczynska, M., K. L. Rock, T. Spies, and A. L. Goldberg. 1994. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP 2 and LMP 7. Proc. Natl. Acad. Sci. USA 91-9213.
12. Kuckelkorn, U., S. Frentzel, R. Kraft, S. Kostka, M. Groettrup, and P.-M. Kloetzel. 1995. Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-γ. Eur. J. Immunol. 25:2605.
13. Groettrup, M., T. Ruppert, L. Kuehn, M. Seeger, S. Standera, U. Koszinowski, and P. M. Kloetzel. 1995. The interferon-γ-inducible 11S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20S proteasome in vitro. J. Biol. Chem. 270:23808.
14. Eleuteri, A. M., R. A. Kohanski, C. Cardozo, and M. Orlowski. 1997. Bovine spleen multicatalytic proteinase complex (proteasome): replacement of X, Y, and Z subunits by LMP7, LMP2, and MECL1 and changes in properties and specificity. J. Biol. Chem. 272:11824.
15. Fehling, H. J., W. Swat, C. Laplace, R. Kuehn, K. Rajewsky, U. Mueller, and H. von Boehmer. 1994. MHC class I expression in mice lacking proteasome subunit LMP-7. Science 265:1234.
16. Van Kaer, L., P. G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A. L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP 2 mutant mice. Immunity 1:533.
17. Arnold, D., J. Driscoll, M. Androlewicz, E. Hughes, P. Cresswell, and T. Spies. 1993. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature 360:171.
18. Momburg, F., V. Ortiz-Navarrete, J. Neefjes, E. Goulmy, Y. van-de-Wal, H. Spits, S. J. Powis, G. W. Butcher, J. C. Howard, P. Walden, and G. Haemmerling. 1993. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature 360:174.
19. Yewdell, J., C. Lapham, I. Bacik, T. Spies, and J. Bennink. 1994. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation. J. Immunol. 152:1163.
20. d in proteasome subunit LMP2-and LMP7-deficient cells. Eur. J. Immunol. 24:1863.
21. + proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. Curr. Bio. 5:923.
22. Hisamatsu, H., N. Shimbara, Y. Saito, P. Kristensen, K. B. Hendil, T. Fujiwara, E.-i. Takahashi, N. Tanahashi, T. Tamura, A. Ichihara, and K. Tanaka. 1996. Newly identified pair of proteasomal subunits regulated reciprocally by interferon γ. J. Exp. Med. 183:1.
23. Groettrup, M., R. Kraft, S. Kostka, S. Standera, R. Stohwasser, and P.-M. Kloetzel. 1996. A third interferon-γ-induced subunit exchange in the 20S proteasome. Eur. J. Immunol. 26:863.
24. Nandi, D., H. Jiang, and J. J. Monaco. 1996. Identification of MECL-1 (LMP-10) as the third IFN-γ-inducible proteasome subunit. J. Immunol. 156:2361.
25. Groettrup, M., S. Standera, R. Stohwasser, and P. M. Kloetzel. 1997. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc. Natl. Acad. Sci. USA 94:8970.
26. Griffin, T. A., D. Nandi, M. Cruz, H. J. Fehling, L. VanKaer, J. J. Monaco, and R. A. Colbert. 1998. Immunoproteasome assembly: cooperative incorporation of interferon γ (IFN-γ)-inducible subunits. J. Exp. Med. 187:97.
27. Ahn, J. Y., N. Tanahashi, K.-y. Akiyama, H. Hisamatsu, C. Noda, K. Tanaka, C. H. Chung, N. Shibmara, P. J. Willy, J. D. Moit, et al. 1995. Primary structures of two homologous subunits of PA28, a γ-interferon-inducible protein activator of the 20S proteasome. FEBS Lett. 366:37.
28. Gray, C. W., C. A. Slaughter, and G. N. DeMartino. 1994. PA28 activator protein forms regulatory caps on proteasome stacked rings. J. Mol. Biol. 236:7.
29. Knowlton, J. R., S. C. Johnston, F. G. Whitby, C. Realini, Z. G. Zhang, M. Rechsteiner, and C. P. Hill. 1997. Structure of the proteasome activator REG α (PA28α). Nature 390:639.
30. Zhang, Z. G., A. Krutchinsky, S. Endicott, C. Realini, M. Rechsteiner, and K. G. Standing. 1999. Proteasome activator 11S REG or PA28: recombinant REGα/REGβ hetero-oligomers are heptamers. Biochemistry 38:5651.
31. Song, X. L., J. vonKampen, C. A. Slaughter, and G. N. DeMartino. 1997. Relative functions of the a and β subunits of the proteasome activator, PA28. J. Biol. Chem. 272:27994.
32. Realini, C., C. C. Jensen, Z. G. Zhang, S. C. Johnston, J. R. Knowlton, C. P. Hill, and M. Rechsteiner. 1997. Characterization of recombinant REGα, REGβ, and REGy proteasome activators. J. Biol. Chem. 272:25483.
33. Zhang, Z. G., A. Clawson, and M. Rechsteiner. 1998. The proteasome activator 11 S regulator or PA28: contribution by both α and β subunits to proteasome activation. J. Biol. Chem. 273:30660.
34. Groettrup, M., A. Soza, M. Eggers, L. Kuehn, T. P. Dick, H. Schild, H.-G. Rammensee, U. H. Koszinowski, and P.-M. Kloetzel. 1996. A role for the proteasome regulator PA28α in antigen presentation. Nature 381:166.
35. Dick, T. P., T. Ruppert, M. Groettrup, P. M. Kloetzel, L. Kuehn, U. H. Koszinowski, S. Stevanovic', H. Schild, and H.-G. Rammensee. 1996. Coordinated dual cleavages by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86:253.
36. Niedermann, G., R. Grimm, E. Geier, M. Maurer, C. Realini, C. Gartmann, J. Soll, S. Omura, M. C. Rechsteiner, W. Baumeister, and K. Eichmann. 1997. Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system. J. Exp. Med. 186:209.
37. Schulz, M., P. Aichele, M. Vollenweider, F. W. Bobe, F. Cardinaux, H. Hengartner, and R. M. Zinkemagel. 1989. Major histocompatibility complex-dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19:1657.
38. Schwarz, K., R. de Giuli, G. Schmidtke, S. Kostka, M. van den Broek, K. Kim, C. M. Crews, R. Kraft, and M. Groettrup. 2000. The selective proteasome inhibitors lactacystin and expoxomicin can be used to either up-or down-regulate antigen presentation at non-toxic doses. J. Immunol. In press.
39. Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10:1.
40. Soza, A., M. Groettrup, P. Henklein, K. Tanaka, and P. M. Kloetzel. 1997. Expression and subcellular localization of mouse 20S proteasome PA28 regulator. FEBS Lett. 406:27.
41. Battegay, M., S. Cooper, A. Althage, J. Banziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24-or 96-well plates. J. Virol. Methods 33:191.
42. Bruns, M., J. Cihak, G. Müller, and F. Lehmann-Grube. 1983. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology 130:247.
43. Salter, R. D., and P. Cresswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 5:943.
44. Sanderson, S., and N. Shastri. 1994. lacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6:369.
45. Elliott, T., A. Willis, V. Cerundolo, and A. Townsend. 1995. Processing of major histocompatibility class 1-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1481.
46. Boehm, U., L. Gucthlein, T. Klamp, K. Ozbek, A. Schaub, A. Fütterer, K. Pfeffer, and J. C. Howard. 1998. Two families of GTPases dominate the complex cellular response to IFN-γ. J. Immunol. 161:6715.
47. von Herrath, M. G., B. Coon, and M. B. A. Oldstone. 1997. Low-affinity cytotoxic T-lymphocytes require IFN-γ to clear an acute viral infection. Virology 229:349.
48. Cerundolo, V., A. Kelly, T. Elliot, J. Trowsdale, and A. Townsend. 1995. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur. J. Immunol. 25:554.
49. Schmidtke, G., M. Eggers, T. Ruppert, M. Groettrup, U. Koszinowski, and P. M. Kloetzel. 1998. Inactivation of a defined active site in the mouse 20S proteasome complex enhances MHC class I antigen presentation of a mouse cytomegalovirus protein. J. Exp. Med. 187:1641.
50. Shimbara, N., K. Ogawa, Y. Hidaka, H. Nakajima, N. Yamasaki, S. Niwa, N. Tanahashi, and K. Tanaka. 1998. Contribution of proline residue for efficient production of MHC class I ligands by proteasomes. J. Biol. Chem. 273:23062.
51. Bogyo, M., S. Shin, J. S. McMaster, and H. L. Ploegh. 1998. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem. Biol. 5:307.
52. Orlowski, M., C. Cardozo, A. M. Eleuteri, R. Kohanski, C. M. Kam, and J. C. Powers. 1997. Reactions of [C-14]-3.4-dichloroisocoumarin with subunits of pituitary and spleen multicatalylic proteinase complexes (proteasomes). Biochemistry 36:13946.
53. Nussbaum, A. K., T. P. Dick, W. Keilholz, M. Schirle, S. Stevanovic, K. Dietz, W. Heinemeyer, M. Groll, D. H. Wolf, R. Huber, et al. 1998. Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolase I. Proc. Natl. Acad. Sci. USA 95:12504.
54. Groll, M., L. Ditzel, J. Löwe, D. Stock, M. Bochtler, H. D. Bartunik, and R. Huber. 1997. Structure of 20 S proteasome from yeast at 2.4A resolution. Nature 386:463.
55. Heinemeyer, W., M. Fischer, T. Krimmer, U. Stachon, and D. H. Wolf. 1997. The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J. Biol. Chem. 272:25200.
56. Salzmann, U., S. Kral, B. Braun, S. Standera, M. Schmidt, P. M. Kloetzel, and A. Sijts. 1999. Mutational analysis of subunit iβ2 (MECL-1) demonstrates conservation of cleavage specificity between yeast and mammalian proteasomes. FEBS Lett. 454:11.
57. Sewell, A. K., D. A. Price, H. Teisserenc, B. L. Booth, U. Gileadi, F. M. Flavin, J. Trowsdale, R. E. Phillips, and V. Cerundolo. 1999. IFN-γ exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. J. Immunol. 162: 7075.
58. Gileadi, U., H. T. MoinsTeisserenc, I. Correa, B. L. Booth, P. R. Dunbar, A. K. Sewell, J. Trowsdale, R. E. Phillips, and V. Cerundolo. 1999. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. J. Immunol. 163:6045.
59. Sijts, A. J. A. M., T. Ruppert, B. Rehermann, M. Schmidt, U. Koszinowski, and P. M. Kloetzel. 2000. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J. Exp. Med. 191:503.
60. Morel, S., F. Levy, O. BurletSchiltz, F. Brasseur, M. ProbsiKepper, A. L. Peitrequin, B. Monsarrat, R. VanVelthoven, J. C. Cerottini, T. Boon, et al. 2000. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12: 107.
61. Moskophidis, D., M. Baltegay, M. A. Bruendler, E. Laine, I. Gresser, and R. M. Zinkernagel. 1994. Resistance of lymphocytic choriomeningitis virus to α/β interferon and to γ interferon. J. Virol. 68:1951.
62. Wille, A., A. Gessner, H. Lother, and F. Lehmann-Grube. 1989. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocylic choriomeningitis virus-infected mice with anti-interferon-γ monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. Eur. J. Immunol. 19:1283.
63. Müller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918.
64. Stohwasser, R., S. Standera, I. Peters, P.-M. Kloetzel, and M. Groettrup. 1997. Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: reciprocally regulated tissue expression of interferon-γ-modulated proteasome subunits. Eur. J. Immunol. 27:1182.